We know NIV works well for patients with acute COPD or acute CHF exacerbations. In this episode we discuss the evidence for NIV not only in COPD and CHF, but also a myriad of other conditions. Do you know what the latest guidelines say on NIV for asthma, immunocompromised patients, or undifferentiated acute respiratory failure? Take a listen!
You can get CME credit for this episode hereClick here for CME Account Creation Instructions
ED Pharmacist extraordinaire Jill Logan joins CCPEM to discuss the use of high-dose nitroglycerin in patients with acute cardiogenic pulmonary edema. Is it safe? ...
It’s time for our annual literature update of the best and most discussed articles from 2016! Simply a great discussion on important topics such...
Up to 25% of critically ill patients who undergo RSI and endotracheal intubation (ETI) may suffer cardiovascular collapse.? Many clinicians administer IVFs during RSI...